| A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses TK Tan, P Rijal, R Rahikainen, AH Keeble, L Schimanski, S Hussain, ... Nature communications 12 (1), 542, 2021 | 245 | 2021 |
| A delicate balance between antibody evasion and ACE2 affinity for Omicron BA. 2.75 J Huo, A Dijokaite-Guraliuc, C Liu, D Zhou, HM Ginn, R Das, P Supasa, ... Cell reports 42 (1), 2023 | 41 | 2023 |
| A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 N Gupta, A Townsend, P Rijal, J Xiao, TK Tan, KYA Huang, L Schimanski, ... Springer Nature Limited, 2021 | | 2021 |
| A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 A Townsend, P Rijal, J Xiao, TK Tan, KYA Huang, L Schimanski, J Huo, ... Nature communications 12 (1), 1951, 2021 | 64 | 2021 |
| A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19 J Huo, H Mikolajek, A Le Bas, JJ Clark, P Sharma, A Kipar, J Dormon, ... Nature communications 12 (1), 5469, 2021 | 115 | 2021 |
| A Protein Expression Toolkit for Studying Signaling in T Cells AM Santos, J Huo, D Hatherley, M Chirifu, SJ Davis The Immune Synapse: Methods and Protocols, 451-472, 2017 | | 2017 |
| An investigation of hierachical protein recruitment to the inhibitory platelet receptor, G6B-b CH Coxon, AJ Sadler, J Huo, RD Campbell PloS one 7 (11), e49543, 2012 | 29 | 2012 |
| Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases AH Lippert, C Paluch, M Gaglioni, MT Vuong, J McColl, E Jenkins, ... Immunity 57 (2), 256-270. e10, 2024 | 5 | 2024 |
| Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... Cell 185 (14), 2422-2433. e13, 2022 | 625 | 2022 |
| Antigenic characterization of SARS-CoV-2 Omicron subvariant BA. 4.6 A Dijokaite-Guraliuc, R Das, R Nutalai, D Zhou, AJ Mentzer, C Liu, ... Cell Discovery 8 (1), 127, 2022 | 5 | 2022 |
| Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB. 1.5, BQ. 1, BQ. 1.1, BF. 7 and BA. 2.75. 2 A Zhu, P Wei, M Man, X Liu, T Ji, J Chen, C Chen, J Huo, Y Wang, J Zhao Signal transduction and targeted therapy 8 (1), 125, 2023 | 29 | 2023 |
| Architecture of cell–cell junctions in situ reveals a mechanism for bacterial biofilm inhibition CE Melia, JR Bolla, S Katharios-Lanwermeyer, DB Mihaylov, ... Proceedings of the National Academy of Sciences 118 (31), e2109940118, 2021 | 33 | 2021 |
| Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes H Mikolajek, M Weckener, ZF Brotzakis, J Huo, EV Dalietou, A Le Bas, ... Proceedings of the National Academy of Sciences 119 (31), e2205412119, 2022 | 17 | 2022 |
| Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammals JL Parker, JC Deme, Z Wu, G Kuteyi, J Huo, RJ Owens, PC Biggin, ... Science advances 7 (35), eabh3355, 2021 | 36 | 2021 |
| Cryptic pathogen-sugar interactions revealed by universal saturation transfer analysis CJ Buchanan, B Gaunt, PJ Harrison, Y Yang, J Liu, A Khan, AM Giltrap, ... BioRxiv, 2021.04. 14.439284, 2021 | 7 | 2021 |
| Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation A Kennedy, E Waters, B Rowshanravan, C Hinze, C Williams, D Janman, ... Nature immunology 23 (9), 1365-1378, 2022 | 102 | 2022 |
| Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19 SP Graham, RK McLean, AJ Spencer, S Belij-Rammerstorfer, D Wright, ... NPJ vaccines 5 (1), 69, 2020 | 150 | 2020 |
| Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy M Ragonnet-Cronin, R Nutalai, J Huo, A Dijokaite-Guraliuc, R Das, ... Nature Communications 14 (1), 3334, 2023 | 25 | 2023 |
| Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2 M Ragonnet-Cronin, R Nutalai, J Huo, A Dijokaite-Guraliuc, R Das, ... bioRxiv, 2022.07. 14.500063, 2022 | 3 | 2022 |
| GPC3-Unc5 receptor complex structure and role in cell migration O Akkermans, C Delloye-Bourgeois, C Peregrina, M Carrasquero-Ordaz, ... Cell 185 (21), 3931-3949. e26, 2022 | 19 | 2022 |
